VITAMIN D DEFICIENCY IN PATIENTS WITH ALOPECIA AERATA, AND RESPONSIVENESS TO VITAMIN D ANALOGUES: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/7sa3eh95Keywords:
Vitamin D, Alopecia aerate, autoimmune.Abstract
Background: Alopecia areata (AA) is a type of T cell-mediated autoimmune disease involving hair follicles (HF), which is manifested as round or oval non-cicatricial alopecia on the head, but also can occur anywhere in the body. The global morbidity of AA ranges from 0.1% to 0.2%, affecting the population of all ages without significant difference between genders. Vitamin D deficiency is common in alopecia aerata, but there is limited evidence to determine whether vitamin D supplementation improves alopecia aerata currently.
The aim: This study aims to show vitamin D deficiency in patients with alopecia aerata, and responsiveness to vitamin D analogues.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 46 articles, whereas the results of our search on SagePub brought up 74 articles. The results of the search conducted for the last year of 2013 yielded a total 43 articles for PubMed and 20 articles for SagePub. The result from title screening, a total 20 articles for PubMed and 3 articles for SagePub. In the end, we compiled a total of 10 papers. We included five research that met the criteria.
Conclusion: Vitamin D deficiency in alopecia aerata correlates inversely with disease severity and duration. Vitamin D receptor expression is reduced in alopecia aerata and inversely correlate with inflammation histologically but does not correlates with serum vitamin D levels, severity, pattern, or duration of illness.
References
Lin X, Meng X, Song Z. Vitamin D and alopecia areata: Possible roles in pathogenesis and potential implications for therapy. Am J Transl Res. 2019;11(9):5285–300.
Zhu B, Zhang L, Wang J, Tan G. Vitamin D supplementation for patients with alopecia areata: A protocol for systematic review and meta-analysis. Med (United States). 2022;101(42):E31089.
Liu Y, Li J, Liang G, Cheng C, Li Y, Wu X. Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic Review and Meta-analysis. Dermatol Ther (Heidelb) [Internet]. 2020;10(5):967–83. Available from: https://doi.org/10.1007/s13555-020-00433-4
Manchanda Y, Das S, Sarda A, Biswas P. Controversies in the Management of Cutaneous Adverse Drug Reactions Systemic Corticosteroids in the Management of SJS / TEN : Is it Still. Indian J Dermatol [Internet]. 2018;63(2):125–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0
&doi=10.4103%2Fijd.IJD_585_17&partnerID=40&md5=24ac1ecf391acb36c5e83a65633c1c90
Kiszewski AE, Bevilaqua M, Abreu LB De. Alopecia Areata : A New Therapeutic. Int J Trichology. 2018;9(1):50–3.
Erpolat S, Sarifakioglu E, Ayyildiz A. 25-hydroxyvitamin D status in patients with alopecia areata. Postep Dermatologii i Alergol. 2017;34(3):248–52.
An I, Harman M, Ibiloglu I. Topical Ciclopirox Olamine 1%: Revisiting a Unique Antifungal. Indian Dermatol Online J. 2017;10(4):481–5.
Fahim M, Khoso H, Hussain A, Bakhtiar R. Deficiency in alopecia areata and responsiveness to vitamin D analogues: A prospective trial. J Pakistan Assoc Dermatologists. 2023;33(4):1242–8.
Gerkowicz A, Chyl-Surdacka K, Krasowska D, Chodorowska G. The role of vitamin D in non-scarring alopecia. Int J Mol Sci. 2017;18(12):1–12.
Molinelli E, Campanati A, Brisigotti V, Sapigni C, Paolinelli M, Offidani A. Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study. Dermatol Ther (Heidelb) [Internet]. 2020;10(3):515–21. Available from: https://doi.org/10.1007/s13555-020-00379-7
Bakry O, El Farargy S, El Shafiee M, Soliman A. Serum Vitamin D in patients with alopecia areata. Indian Dermatol Online J. 2016;7(5):371.
Lee S, Kim BJ, Lee CH, Lee WS. Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatology Venereol. 2018;32(7):1214–21.
Prochaska J, Benowitz N. 乳鼠心肌提取 HHS Public Access. Physiol Behav. 2016;176(1):100–106.
Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The Role of Vitamins and Minerals in Hair Loss: A Review. Dermatol Ther (Heidelb) [Internet]. 2019;9(1):51–70. Available from: https://doi.org/10.1007/s13555-018-02786
Daroach M, Narang T, Saikia UN, Sachdeva N, Sendhil Kumaran M. Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm. Int J Dermatol. 2018;57(2):217–22.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
